表紙
市場調查報告書
商品編碼
971214

熱原測試的全球市場(-2025年):產品和服務(測定/試劑盒/試劑,設備,服務),測試類型(LAL,顯色,濁度,凝膠化,體外,兔子),最終用戶(藥物,生物)技術/醫療設備)/地區

Pyrogen Testing Market by Product & Service(Assays, Kits, Reagents, Instruments, Services), Test Type(LAL, Chromogenic, Turbidimetric, Gel Clot, In Vitro, Rabbit), End User(Pharmaceutical, Biotechnology, Medical Device), Region - Global Forecast to 2025

出版日期: | 出版商: MarketsandMarkets | 英文 166 Pages | 訂單完成後即時交付

價格
  • 全貌
  • 簡介
  • 目錄
簡介

在預測期間,全球高溫測試市場規模將保持12.7%的複合年增長率,從2020年的9.27億美元增長至2025年的16.89億美元,複合年均增長率。預計為12.7%。諸如傳染病的發生率增加,大流行的頻率增加,製藥和生物技術行業的研發增加,對個性化醫學的重視以及慢性病的流行等因素將推動市場增長。我們正在推廣。另一方面,高度的市場整合有望在未來幾年內抑制市場增長。

按測試類型,LAL測試部門顯示出較高的增長率。對創新臨床測試的需求不斷增長,健康標準的提高,藥物管道的擴展以及對疫苗開發的更多支持等因素正在推動該領域的發展。按最終用戶計算,製藥和生物技術公司部門的複合年增長率最高。此外,按地區劃分,預計亞太地區在預測期內的複合年增長率最高。中國和日本的增長,大型公司向新興亞洲國家的擴張以及向印度和中國的醫藥外包的增長趨勢等因素正在推動該地區的增長。

該報告調查了全球熱原測試市場,分析了市場定義和概述,價值鏈,新型冠狀病毒感染(COVID-19)和其他市場影響因素以及市場規模的變化。它概述了預測,按產品和服務,測試類型,最終用戶,地區/主要國家,競爭環境,主要公司的概況等各種類別細分。

第1章簡介

第2章調查方法

第3章執行摘要

第4章重要注意事項

第5章市場概述

  • 市場動態
    • 促進因素
    • 抑制因素
    • 市場機會
    • 趨勢
  • COVID-19的影響
  • 價格分析
  • 價值鏈分析
  • 供應鏈分析
  • 生態系統分析
  • 波特的五力分析

第6章市場分析/預測:按產品/服務分類

  • 分析/試劑盒/試劑
  • 設備
  • 服務

第7章市場分析/預測:按測試類型

  • LAL測試
    • 顯色測試
    • 濁度測試
    • 膠凝試驗
  • 體外測試
  • 兔子測試

第8章市場分析/預測:按最終用戶

  • 製藥和生物技術公司
  • 醫療設備公司
  • 其他

第9章市場分析/預測:按地區/主要國家/地區

  • 北美
    • 美國
    • 加拿大
  • 歐洲
    • 德國
    • 英國
    • 法國
    • 意大利
    • 西班牙
    • 其他
  • 亞太地區
    • 中國
    • 日本
    • 印度
    • 其他
  • 拉丁美洲
  • 中東/非洲

第10章競爭情況

  • 概述
  • 市場份額分析
  • 企業評估象限
  • 競爭情景

第11章公司簡介

  • 主要公司
    • CHARLES RIVER LABORATORIES, INC.
    • LONZA
    • MERCK KGAA
    • THERMO FISHER SCIENTIFIC, INC.
    • ASSOCIATES OF CAPE COD, INC.
    • BIOMERIEUX SA
    • GENSCRIPT BIOTECH CORPORATION
    • EUROFINS SCIENTIFIC
    • WUXI APPTEC
    • STERIS PLC
  • 其他公司
    • ELLAB A/S
    • FUJIFILM WAKO PURE CHEMICAL CORPORATION
    • INVIVOGEN
    • NELSON LABORATORIES, LLC
    • MICROCOAT BIOTECHNOLOGIE GMBH
    • HYCULT BIOTECH
    • ALMAC GROUP
    • PACIFIC BIOLABS
    • ACCUGEN LABORATORIES, INC.
    • TOXIKON
    • MINERVA ANALYTIX GMBH
    • INDOOR BIOTECHNOLOGIES, INC.
    • CREATIVE BIOARRAY
    • LUCIDEON LIMITED
    • NORTH AMERICAN SCIENCE ASSOCIATES, INC.

第12章附錄

目錄
Product Code: BT 3175

The global pyrogen testing market size is projected to reach USD 1,689 million by 2025 from USD 927 million in 2020, at a CAGR of 12.7% during the forecast period. Market growth is driven by factors such as the rising incidence of infectious diseases and increasing pandemics frequency, increasing R & D in the pharmaceutical and biotechnology industries, growing focus on personalized medicine, and the rising prevalence of chronic diseases. On the other hand, the high degree of market consolidation is expected to limit market growth to a certain extent in the coming years.

"The assays, kits, & reagents accounted for the highest growth rate in the pyrogen testing market, by product & service, during the forecast period"

The pyrogen testing market is segmented into assays, kits, & reagents, instruments, and services based on product & service. The assays, kits, & reagents segment accounted for the highest growth rate in the pyrogen testing market in 2019. The requirement of assays, kits, & reagents in large numbers compared to instruments is the main factor contributing to this segment's high growth rate. This segment's market growth can also be attributed to repeat purchases of assays, kits, & reagents compared to instruments and the rising preference for kit-based testing.

"LAL tests segment accounted for the highest CAGR"

Based on the test type, the pyrogen testing market is segmented into LAL tests, in vitro tests, and rabbit tests. The LAL tests segment is further categorized into chromogenic tests, turbidimetric tests, and gel clot tests. In 2019, the LAL tests segment accounted for the highest growth rate. The rising need for innovative laboratory testing procedures, increasing health standards, growing drug pipelines, and the increasing support for vaccine development are the major factors driving this segment's growth.

"Pharmaceutical & biotechnology companies segment accounted for the highest CAGR"

Based on end-users, the pyrogen testing market is segmented into pharmaceutical & biotechnology companies, medical device companies, and other end users. In 2019, the pharmaceutical & biotechnology companies segment accounted for the highest growth rate. This can be attributed to many ongoing drug discovery activities and the increasing number of R&D facilities globally.

"Asia Pacific: The fastest-growing region pyrogen testing market"

The global pyrogen testing market is segmented into North America, Europe, Asia Pacific, Latin America, and the Middle East & Africa. The Asia Pacific region is projected to register the highest CAGR during the forecast period. Growth in this region is expected to be centered on China and Japan. Factors such as the expansion by key market players in emerging Asian countries and the increasing trend of pharmaceutical outsourcing to Asian countries like India and China are driving the growth of the pyrogen testing market in this region.

The primary interviews conducted for this report can be categorized as follows:

  • By Company Type: Tier 1 - 40%, Tier 2 - 30%, and Tier 3 - 30%
  • By Designation: C-level - 27%, D-level - 18%, and Others - 55%
  • By Region: North America - 51%, Europe - 21%, Asia Pacific - 18%, Latin America - 6% , and the Middle East & Africa - 4%

Lits of Companies Profiled in the Report:

  • Charles River Laboratories, Inc. (US)
  • Lonza (Switzerland)
  • Merck KGaA (Germany)
  • Thermo Fisher Scientific, Inc. (US)
  • Associates of Cape Cod, Inc. (US)
  • GenScript Biotech Corporation (China)
  • bioMerieux SA (France)
  • FUJIFILM Wako Pure Chemical Corporation (Japan)
  • Eurofins Scientific (Luxembourg)
  • WuXi AppTec (China)
  • Hycult Biotech (Netherlands)
  • Ellab A/S (Denmark)
  • Microcoat Biotechnologie GmbH (Germany)
  • InvivoGen (US)
  • Nelson Laboratories, LLC (US)
  • Almac Group (UK)
  • Pacific Biolabs (US)
  • STERIS plc (US)
  • Accugen Laboratories, Inc. (US)
  • TOXIKON (US)
  • Minerva Analytix GmbH (Germany)
  • Indoor Biotechnologies, Inc. (US)
  • Creative Bioarray (US)
  • Lucideon Limited (UK)
  • North American Science Associates, Inc. (US)

Research Coverage:

This report provides a detailed picture of the global pyrogen testing market. It aims at estimating the size and future growth potential of the market across different segments, such as product & service, test type, end user, and region. The report also includes an in-depth competitive analysis of the key market players, along with their company profiles, recent developments, and key market strategies.

Key Benefits of Buying the Report:

The report will help market leaders/new entrants by providing them with the closest approximations of the revenue numbers for the overall pyrogen testing market and its subsegments. It will also help stakeholders better understand the competitive landscape and gain more insights to better position their business and make suitable go-to-market strategies. This report will enable stakeholders to understand the market's pulse and provide them with information on the key market drivers, restraints, trends, and opportunities.

TABLE OF CONTENTS

1 INTRODUCTION

  • 1.1 OBJECTIVES OF THE STUDY
  • 1.2 MARKET DEFINITION
    • 1.2.1 INCLUSIONS & EXCLUSIONS
    • 1.2.2 MARKETS COVERED
    • FIGURE 1 PYROGEN TESTING MARKET
    • 1.2.3 YEARS CONSIDERED FOR THE STUDY
  • 1.3 CURRENCY
  • 1.4 LIMITATIONS
  • 1.5 STAKEHOLDERS
  • 1.6 SUMMARY OF CHANGES
    • 1.6.1 LIMITATIONS OF THE CURRENT EDITION

2 RESEARCH METHODOLOGY

  • 2.1 RESEARCH DATA
  • 2.2 RESEARCH APPROACH
    • FIGURE 2 PYROGEN TESTING MARKET: RESEARCH DESIGN
    • 2.2.1 SECONDARY DATA
      • 2.2.1.1 Key data from secondary sources
    • 2.2.2 PRIMARY DATA
    • FIGURE 3 BREAKDOWN OF PRIMARY INTERVIEWS: BY COMPANY TYPE, DESIGNATION, AND REGION
      • 2.2.2.1 Key data from primary sources
  • 2.3 MARKET SIZE ESTIMATION
    • 2.3.1 BOTTOM-UP APPROACH
    • FIGURE 4 PYROGEN TESTING MARKET: BOTTOM-UP APPROACH
    • 2.3.2 TOP-DOWN APPROACH
    • FIGURE 5 PYROGEN TESTING MARKET: TOP-DOWN APPROACH
  • 2.4 MARKET BREAKDOWN AND DATA TRIANGULATION
    • FIGURE 6 DATA TRIANGULATION METHODOLOGY
  • 2.5 ASSUMPTIONS FOR THE STUDY

3 EXECUTIVE SUMMARY

    • FIGURE 7 PYROGEN TESTING MARKET, BY PRODUCT & SERVICE, 2020 VS. 2025 (USD MILLION)
    • FIGURE 8 PYROGEN TESTING MARKET, BY TEST TYPE, 2020 VS. 2025 (USD MILLION)
    • FIGURE 9 PYROGEN TESTING MARKET, BY END USER, 2020 VS. 2025 (USD MILLION)
    • FIGURE 10 PYROGEN TESTING MARKET, BY REGION, 2020 VS. 2025 (USD MILLION)

4 PREMIUM INSIGHTS

  • 4.1 PYROGEN TESTING MARKET OVERVIEW
    • FIGURE 11 INCREASING R&D IN THE PHARMACEUTICAL & BIOTECHNOLOGY INDUSTRIES IS DRIVING THE GROWTH OF THE PYROGEN TESTING MARKET
  • 4.2 PYROGEN TESTING MARKET, BY PRODUCT & SERVICE, 2020 VS. 2025 (USD MILLION)
    • FIGURE 12 ASSAYS, KITS, & REAGENTS SEGMENT WILL CONTINUE TO DOMINATE THE MARKET IN 2025
  • 4.3 PYROGEN TESTING MARKET SHARE, BY END USER, 2020 VS. 2025
    • FIGURE 13 PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES ARE THE LARGEST END USERS OF PYROGEN TESTING PRODUCTS & SERVICES
  • 4.4 PYROGEN TESTING MARKET: GEOGRAPHIC GROWTH OPPORTUNITIES
    • FIGURE 14 ASIA PACIFIC TO REGISTER THE HIGHEST GROWTH RATE IN THE PYROGEN TESTING MARKET DURING THE FORECAST PERIOD

5 MARKET OVERVIEW

  • 5.1 INTRODUCTION
  • 5.2 MARKET DYNAMICS
    • FIGURE 15 PYROGEN TESTING MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND TRENDS
    • 5.2.1 DRIVERS
      • 5.2.1.1 Rising incidence of infectious diseases and increasing frequency of pandemics
      • 5.2.1.2 Increasing R&D in the pharmaceutical & biotechnology industries
    • FIGURE 16 GLOBAL PHARMACEUTICAL & BIOPHARMACEUTICAL R&D EXPENDITURE, 2017-2024
      • 5.2.1.3 Growing focus on personalized medicine
    • TABLE 1 GROWTH IN THE NUMBER OF PERSONALIZED MEDICATIONS, 2008-2016
      • 5.2.1.4 Growing awareness about food safety
    • FIGURE 17 NUMBER OF FOODBORNE DISEASE OUTBREAKS REPORTED TO ORU/NICD, SOUTH AFRICA, 2013-2017
      • 5.2.1.5 High prevalence of chronic diseases
    • FIGURE 18 INCIDENCE OF DIABETES, BY REGION, 2017 VS. 2045 (MILLION CASES)
    • 5.2.2 RESTRAINTS
      • 5.2.2.1 High degree of consolidation
    • 5.2.3 OPPORTUNITIES
      • 5.2.3.1 Increasing pharmaceutical outsourcing
      • 5.2.3.2 Emerging markets offer lucrative opportunities
    • 5.2.4 TRENDS
      • 5.2.4.1 Shift from animal-based testing to in vitro testing
  • 5.3 IMPACT OF COVID-19 ON THE PYROGEN TESTING MARKET
  • 5.4 PRICING ANALYSIS
    • TABLE 2 PRICE OF PYROGEN TESTING PRODUCTS (2020)
  • 5.5 VALUE CHAIN ANALYSIS
    • FIGURE 19 MAJOR VALUE IS ADDED DURING THE MANUFACTURING & ASSEMBLY PHASE
  • 5.6 SUPPLY CHAIN ANALYSIS
    • FIGURE 20 DISTRIBUTION-A STRATEGY PREFERRED BY PROMINENT COMPANIES
  • 5.7 ECOSYSTEM ANALYSIS OF THE PYROGEN TESTING MARKET
    • FIGURE 21 ECOSYSTEM ANALYSIS OF THE PYROGEN TESTING MARKET
  • 5.8 PORTER'S FIVE FORCES ANALYSIS
    • FIGURE 22 HIGH CAPITAL INVESTMENTS TO RESTRICT THE ENTRY OF NEW PLAYERS
    • 5.8.1 THREAT OF NEW ENTRANTS
    • 5.8.2 THREAT OF SUBSTITUTES
    • 5.8.3 BARGAINING POWER OF BUYERS
    • 5.8.4 BARGAINING POWER OF SUPPLIERS
    • 5.8.5 INTENSITY OF COMPETITIVE RIVALRY

6 PYROGEN TESTING MARKET, BY PRODUCT & SERVICE

  • 6.1 INTRODUCTION
    • TABLE 3 PYROGEN TESTING MARKET, BY PRODUCT & SERVICE, 2018-2025 (USD MILLION)
  • 6.2 ASSAYS, KITS, & REAGENTS
    • 6.2.1 REPEAT PURCHASES OF ASSAYS, KITS, & REAGENTS TO DRIVE THE MARKET GROWTH
    • TABLE 4 PYROGEN TESTING ASSAYS, KITS, & REAGENTS MARKET, BY REGION, 2018-2025 (USD MILLION)
    • TABLE 5 NORTH AMERICA: PYROGEN TESTING ASSAYS, KITS, & REAGENTS MARKET, BY COUNTRY, 2018-2025 (USD MILLION)
    • TABLE 6 EUROPE: PYROGEN TESTING ASSAYS, KITS, & REAGENTS MARKET, BY COUNTRY, 2018-2025 (USD MILLION)
    • TABLE 7 ASIA PACIFIC: PYROGEN TESTING ASSAYS, KITS, & REAGENTS MARKET, BY COUNTRY, 2018-2025 (USD MILLION)
  • 6.3 INSTRUMENTS
    • 6.3.1 CONTINUOUS INNOVATION IN TECHNOLOGICALLY ADVANCED PRODUCTS TO SUPPORT MARKET GROWTH
    • TABLE 8 PYROGEN TESTING INSTRUMENTS MARKET, BY REGION, 2018-2025 (USD MILLION)
    • TABLE 9 NORTH AMERICA: PYROGEN TESTING INSTRUMENTS MARKET, BY COUNTRY, 2018-2025 (USD MILLION)
    • TABLE 10 EUROPE: PYROGEN TESTING INSTRUMENTS MARKET, BY COUNTRY, 2018-2025 (USD MILLION)
    • TABLE 11 ASIA PACIFIC: PYROGEN TESTING INSTRUMENTS MARKET, BY COUNTRY, 2018-2025 (USD MILLION)
  • 6.4 SERVICES
    • 6.4.1 LACK OF EXPERTISE AND INFRASTRUCTURE FOR ANALYTICAL & QUALITY TESTING DRIVES RELIANCE ON SERVICE PROVIDERS
    • TABLE 12 PYROGEN TESTING SERVICES MARKET, BY REGION, 2018-2025 (USD MILLION)
    • TABLE 13 NORTH AMERICA: PYROGEN TESTING SERVICES MARKET, BY COUNTRY, 2018-2025 (USD MILLION)
    • TABLE 14 EUROPE: PYROGEN TESTING SERVICES MARKET, BY COUNTRY, 2018-2025 (USD MILLION)
    • TABLE 15 ASIA PACIFIC: PYROGEN TESTING SERVICES MARKET, BY COUNTRY, 2018-2025 (USD MILLION)

7 PYROGEN TESTING MARKET, BY TEST TYPE

  • 7.1 INTRODUCTION
    • TABLE 16 PYROGEN TESTING MARKET, BY TEST TYPE, 2018-2025 (USD MILLION)
  • 7.2 LAL TESTS
    • TABLE 17 LAL TESTS MARKET, BY REGION, 2018-2025 (USD MILLION)
    • TABLE 18 LAL TESTS MARKET, BY TYPE, 2018-2025 (USD MILLION)
    • 7.2.1 CHROMOGENIC TESTS
      • 7.2.1.1 Ease of use & cost-effectiveness of chromogenic tests to support market growth
    • TABLE 19 KEY PRODUCTS IN THE CHROMOGENIC TESTS MARKET, BY COMPANY
    • TABLE 20 CHROMOGENIC TESTS MARKET, BY REGION, 2018-2025 (USD MILLION)
    • 7.2.2 TURBIDIMETRIC TESTS
      • 7.2.2.1 Higher precision of kinetic turbidimetric tests have supported their adoption
    • TABLE 21 KEY PRODUCTS IN THE TURBIDIMETRIC TESTS MARKET, BY COMPANY
    • TABLE 22 TURBIDIMETRIC TESTS MARKET, BY REGION, 2018-2025 (USD MILLION)
    • 7.2.3 GEL CLOT TESTS
      • 7.2.3.1 Endotoxin determination with gel clot test method is simpler and more economical
    • TABLE 23 KEY PRODUCTS IN THE GEL CLOT TESTS MARKET, BY COMPANY
    • TABLE 24 GEL CLOT TESTS MARKET, BY REGION, 2018-2025 (USD MILLION)
  • 7.3 IN VITRO TESTS
    • 7.3.1 APPLICABILITY TO A GREATER VARIETY OF PRODUCTS IS DRIVING THE GROWTH OF THIS SEGMENT
    • TABLE 25 IN VITRO TESTS MARKET, BY REGION, 2018-2025 (USD MILLION)
  • 7.4 RABBIT TESTS
    • 7.4.1 INCREASING FOCUS ON THE USE OF NON-ANIMAL-BASED TESTING METHODS TO LIMIT MARKET GROWTH
    • TABLE 26 RABBIT TESTS MARKET, BY REGION, 2018-2025 (USD MILLION)

8 PYROGEN TESTING MARKET, BY END USER

  • 8.1 INTRODUCTION
    • TABLE 27 PYROGEN TESTING MARKET, BY END USER, 2018-2025 (USD MILLION)
  • 8.2 PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES
    • 8.2.1 PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES ARE THE LARGEST END USERS OF PYROGEN TESTING PRODUCTS
    • TABLE 28 PYROGEN TESTING MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY REGION, 2018-2025 (USD MILLION)
  • 8.3 MEDICAL DEVICE COMPANIES
    • 8.3.1 RISING NEED TO ENSURE THE SAFETY OF MANUFACTURED MEDICAL DEVICES HAS DRIVEN THE ADOPTION OF PYROGEN TESTING PRODUCTS
    • TABLE 29 PYROGEN TESTING MARKET FOR MEDICAL DEVICE COMPANIES, BY REGION, 2018-2025 (USD MILLION)
  • 8.4 OTHER END USERS
    • TABLE 30 PYROGEN TESTING MARKET FOR OTHER END USERS, BY REGION, 2018-2025 (USD MILLION)

9 PYROGEN TESTING MARKET, BY REGION

  • 9.1 INTRODUCTION
    • TABLE 31 PYROGEN TESTING MARKET, BY REGION, 2018-2025 (USD MILLION)
  • 9.2 NORTH AMERICA
    • FIGURE 23 NORTH AMERICA: PYROGEN TESTING MARKET SNAPSHOT
    • TABLE 32 NORTH AMERICA: PYROGEN TESTING MARKET, BY COUNTRY, 2018-2025 (USD MILLION)
    • TABLE 33 NORTH AMERICA: PYROGEN TESTING MARKET, BY PRODUCT & SERVICE, 2018-2025 (USD MILLION)
    • TABLE 34 NORTH AMERICA: PYROGEN TESTING MARKET, BY TEST TYPE, 2018-2025 (USD MILLION)
    • TABLE 35 NORTH AMERICA: LAL TESTS MARKET, BY TYPE, 2018-2025 (USD MILLION)
    • TABLE 36 NORTH AMERICA: PYROGEN TESTING MARKET, BY END USER, 2018-2025 (USD MILLION)
    • 9.2.1 US
      • 9.2.1.1 The US dominates the North American market
    • TABLE 37 US: PYROGEN TESTING MARKET, BY PRODUCT & SERVICE, 2018-2025 (USD MILLION)
    • TABLE 38 US: PYROGEN TESTING MARKET, BY TEST TYPE, 2018-2025 (USD MILLION)
    • TABLE 39 US: LAL TESTS MARKET, BY TYPE, 2018-2025 (USD MILLION)
    • TABLE 40 US: PYROGEN TESTING MARKET, BY END USER, 2018-2025 (USD MILLION)
    • 9.2.2 CANADA
      • 9.2.2.1 Support from government organizations is driving the growth of the pyrogen testing market in Canada
    • TABLE 41 CANADA: PYROGEN TESTING MARKET, BY PRODUCT & SERVICE, 2018-2025 (USD MILLION)
    • TABLE 42 CANADA: PYROGEN TESTING MARKET, BY TEST TYPE, 2018-2025 (USD MILLION)
    • TABLE 43 CANADA: LAL TESTS MARKET, BY TYPE, 2018-2025 (USD MILLION)
    • TABLE 44 CANADA: PYROGEN TESTING MARKET, BY END USER, 2018-2025 (USD MILLION)
  • 9.3 EUROPE
    • TABLE 45 EUROPE: PYROGEN TESTING MARKET, BY COUNTRY, 2018-2025 (USD MILLION)
    • TABLE 46 EUROPE: PYROGEN TESTING MARKET, BY PRODUCT & SERVICE, 2018-2025 (USD MILLION)
    • TABLE 47 EUROPE: PYROGEN TESTING MARKET, BY TEST TYPE, 2018-2025 (USD MILLION)
    • TABLE 48 EUROPE: LAL TESTS MARKET, BY TYPE, 2018-2025 (USD MILLION)
    • TABLE 49 EUROPE: PYROGEN TESTING MARKET, BY END USER, 2018-2025 (USD MILLION)
    • 9.3.1 GERMANY
      • 9.3.1.1 Germany holds the largest share of the European market
    • TABLE 50 GERMANY: PYROGEN TESTING MARKET, BY PRODUCT & SERVICE, 2018-2025 (USD MILLION)
    • TABLE 51 GERMANY: PYROGEN TESTING MARKET, BY TEST TYPE, 2018-2025 (USD MILLION)
    • TABLE 52 GERMANY: LAL TESTS MARKET, BY TYPE, 2018-2025 (USD MILLION)
    • TABLE 53 GERMANY: PYROGEN TESTING MARKET, BY END USER, 2018-2025 (USD MILLION)
    • 9.3.2 UK
      • 9.3.2.1 Growth of the pharmaceutical & biotechnology industry to drive the market in the UK
    • TABLE 54 UK: PYROGEN TESTING MARKET, BY PRODUCT & SERVICE, 2018-2025 (USD MILLION)
    • TABLE 55 UK: PYROGEN TESTING MARKET, BY TEST TYPE, 2018-2025 (USD MILLION)
    • TABLE 56 UK: LAL TESTS MARKET, BY TYPE, 2018-2025 (USD MILLION)
    • TABLE 57 UK: PYROGEN TESTING MARKET, BY END USER, 2018-2025 (USD MILLION)
    • 9.3.3 FRANCE
      • 9.3.3.1 Increasing investments in life science R&D infrastructure development to support market growth
    • TABLE 58 FRANCE: PYROGEN TESTING MARKET, BY PRODUCT & SERVICE, 2018-2025 (USD MILLION)
    • TABLE 59 FRANCE: PYROGEN TESTING MARKET, BY TEST TYPE, 2018-2025 (USD MILLION)
    • TABLE 60 FRANCE: LAL TESTS MARKET, BY TYPE, 2018-2025 (USD MILLION)
    • TABLE 61 FRANCE: PYROGEN TESTING MARKET, BY END USER, 2018-2025 (USD MILLION)
    • 9.3.4 ITALY
      • 9.3.4.1 Growth in this market is mainly driven by increasing life science R&D
    • TABLE 62 ITALY: PYROGEN TESTING MARKET, BY PRODUCT & SERVICE, 2018-2025 (USD MILLION)
    • TABLE 63 ITALY: PYROGEN TESTING MARKET, BY TEST TYPE, 2018-2025 (USD MILLION)
    • TABLE 64 ITALY: LAL TESTS MARKET, BY TYPE, 2018-2025 (USD MILLION)
    • TABLE 65 ITALY: PYROGEN TESTING MARKET, BY END USER, 2018-2025 (USD MILLION)
    • 9.3.5 SPAIN
      • 9.3.5.1 Increasing outsourcing of microbial testing services to fuel the adoption of pyrogen testing
    • TABLE 66 SPAIN: PYROGEN TESTING MARKET, BY PRODUCT & SERVICE, 2018-2025 (USD MILLION)
    • TABLE 67 SPAIN: PYROGEN TESTING MARKET, BY TEST TYPE, 2018-2025 (USD MILLION)
    • TABLE 68 SPAIN: LAL TESTS MARKET, BY TYPE, 2018-2025 (USD MILLION)
    • TABLE 69 SPAIN: PYROGEN TESTING MARKET, BY END USER, 2018-2025 (USD MILLION)
    • 9.3.6 REST OF EUROPE
    • TABLE 70 ROE: PYROGEN TESTING MARKET, BY PRODUCT & SERVICE, 2018-2025 (USD MILLION)
    • TABLE 71 ROE: PYROGEN TESTING MARKET, BY TEST TYPE, 2018-2025 (USD MILLION)
    • TABLE 72 ROE: LAL TESTS MARKET, BY TYPE, 2018-2025 (USD MILLION)
    • TABLE 73 ROE: PYROGEN TESTING MARKET, BY END USER, 2018-2025 (USD MILLION)
  • 9.4 ASIA PACIFIC
    • FIGURE 24 ASIA PACIFIC: PYROGEN TESTING MARKET SNAPSHOT
    • TABLE 74 APAC: PYROGEN TESTING MARKET, BY COUNTRY, 2018-2025 (USD MILLION)
    • TABLE 75 APAC: PYROGEN TESTING MARKET, BY PRODUCT & SERVICE, 2018-2025 (USD MILLION)
    • TABLE 76 APAC: PYROGEN TESTING MARKET, BY TEST TYPE, 2018-2025 (USD MILLION)
    • TABLE 77 APAC: LAL TESTS MARKET, BY TYPE, 2018-2025 (USD MILLION)
    • TABLE 78 APAC: PYROGEN TESTING MARKET, BY END USER, 2018-2025 (USD MILLION)
    • 9.4.1 CHINA
      • 9.4.1.1 China dominates the market in the APAC
    • TABLE 79 CHINA: PYROGEN TESTING MARKET, BY PRODUCT & SERVICE, 2018-2025 (USD MILLION)
    • TABLE 80 CHINA: PYROGEN TESTING MARKET, BY TEST TYPE, 2018-2025 (USD MILLION)
    • TABLE 81 CHINA: LAL TESTS MARKET, BY TYPE, 2018-2025 (USD MILLION)
    • TABLE 82 CHINA: PYROGEN TESTING MARKET, BY END USER, 2018-2025 (USD MILLION)
    • 9.4.2 JAPAN
      • 9.4.2.1 Expansion of pharmaceutical manufacturing plants in Japan to create market growth opportunities
    • TABLE 83 JAPAN: PYROGEN TESTING MARKET, BY PRODUCT & SERVICE, 2018-2025 (USD MILLION)
    • TABLE 84 JAPAN: PYROGEN TESTING MARKET, BY TEST TYPE, 2018-2025 (USD MILLION)
    • TABLE 85 JAPAN: LAL TESTS MARKET, BY TYPE, 2018-2025 (USD MILLION)
    • TABLE 86 JAPAN: PYROGEN TESTING MARKET, BY END USER, 2018-2025 (USD MILLION)
    • 9.4.3 INDIA
      • 9.4.3.1 India's growing contract research and manufacturing industry will favor the pyrogen testing market
    • TABLE 87 INDIA: PYROGEN TESTING MARKET, BY PRODUCT & SERVICE, 2018-2025 (USD MILLION)
    • TABLE 88 INDIA: PYROGEN TESTING MARKET, BY TEST TYPE, 2018-2025 (USD MILLION)
    • TABLE 89 INDIA: LAL TESTS MARKET, BY TYPE, 2018-2025 (USD MILLION)
    • TABLE 90 INDIA: PYROGEN TESTING MARKET, BY END USER, 2018-2025 (USD MILLION)
    • 9.4.4 REST OF ASIA PACIFIC
    • TABLE 91 ROAPAC: PYROGEN TESTING MARKET, BY PRODUCT & SERVICE, 2018-2025 (USD MILLION)
    • TABLE 92 ROAPAC: PYROGEN TESTING MARKET, BY TEST TYPE, 2018-2025 (USD MILLION)
    • TABLE 93 ROAPAC: LAL TESTS MARKET, BY TYPE, 2018-2025 (USD MILLION)
    • TABLE 94 ROAPAC: PYROGEN TESTING MARKET, BY END USER, 2018-2025 (USD MILLION)
  • 9.5 LATIN AMERICA
    • 9.5.1 GROWING CONTRACT RESEARCH & MANUFACTURING ACTIVITIES TO SUPPORT THE MARKET GROWTH
    • TABLE 95 LATIN AMERICA: PYROGEN TESTING MARKET, BY PRODUCT & SERVICE, 2018-2025 (USD MILLION)
    • TABLE 96 LATIN AMERICA: PYROGEN TESTING MARKET, BY TEST TYPE, 2018-2025 (USD MILLION)
    • TABLE 97 LATIN AMERICA: LAL TESTS MARKET, BY TYPE, 2018-2025 (USD MILLION)
    • TABLE 98 LATIN AMERICA: PYROGEN TESTING MARKET, BY END USER, 2018-2025 (USD MILLION)
  • 9.6 MIDDLE EAST & AFRICA
    • 9.6.1 INCREASING R&D INVESTMENTS AND FOCUS ON THE DEVELOPMENT OF NEW DRUGS ARE CONTRIBUTING TO MARKET GROWTH
    • TABLE 99 MIDDLE EAST & AFRICA: PYROGEN TESTING MARKET, BY PRODUCT & SERVICE, 2018-2025 (USD MILLION)
    • TABLE 100 MIDDLE EAST & AFRICA: PYROGEN TESTING MARKET, BY TEST TYPE, 2018-2025 (USD MILLION)
    • TABLE 101 MIDDLE EAST & AFRICA: LAL TESTS MARKET, BY TYPE, 2018-2025 (USD MILLION)
    • TABLE 102 MIDDLE EAST & AFRICA: PYROGEN TESTING MARKET, BY END USER, 2018-2025 (USD MILLION)

10 COMPETITIVE LANDSCAPE

  • 10.1 OVERVIEW
    • FIGURE 25 KEY DEVELOPMENTS IN THE PYROGEN TESTING MARKET
  • 10.2 MARKET SHARE ANALYSIS
    • FIGURE 26 PYROGEN TESTING MARKET SHARE, BY KEY PLAYER (2019)
  • 10.3 COMPANY EVALUATION QUADRANT
    • 10.3.1 VENDOR EXCLUSION CRITERIA
    • 10.3.2 STARS
    • 10.3.3 EMERGING LEADERS
    • 10.3.4 PERVASIVE PLAYERS
    • 10.3.5 PARTICIPANTS
    • FIGURE 27 PYROGEN TESTING MARKET: COMPETITIVE LEADERSHIP MAPPING, 2019
  • 10.4 COMPETITIVE SCENARIO
    • 10.4.1 PRODUCT LAUNCHES
    • TABLE 103 KEY PRODUCT LAUNCHES
    • 10.4.2 ACQUISITIONS
    • TABLE 104 KEY ACQUISITIONS
    • 10.4.3 EXPANSIONS
    • TABLE 105 KEY EXPANSIONS
    • 10.4.4 AGREEMENTS
    • TABLE 106 KEY AGREEMENTS
    • 10.4.5 PARTNERSHIPS
    • TABLE 107 KEY PARTNERSHIPS

11 COMPANY PROFILES

  • 11.1 KEY PLAYERS

(Business Overview, Products Offered, Recent Developments, MnM View)**

    • 11.1.1 CHARLES RIVER LABORATORIES, INC.
    • FIGURE 28 CHARLES RIVER LABORATORIES, INC.: COMPANY SNAPSHOT (2019)
    • 11.1.2 LONZA
    • FIGURE 29 LONZA: COMPANY SNAPSHOT (2019)
    • 11.1.3 MERCK KGAA
    • FIGURE 30 MERCK KGAA: COMPANY SNAPSHOT (2019)
    • 11.1.4 THERMO FISHER SCIENTIFIC, INC.
    • FIGURE 31 THERMO FISHER SCIENTIFIC, INC.: COMPANY SNAPSHOT (2019)
    • 11.1.5 ASSOCIATES OF CAPE COD, INC.
    • 11.1.6 BIOMERIEUX SA
    • FIGURE 32 BIOMERIEUX SA: COMPANY SNAPSHOT (2019)
    • 11.1.7 GENSCRIPT BIOTECH CORPORATION
    • FIGURE 33 GENSCRIPT BIOTECH CORPORATION: COMPANY SNAPSHOT (2019)
      • 11.1.7.2 Products offered
    • 11.1.8 EUROFINS SCIENTIFIC
    • FIGURE 34 EUROFINS SCIENTIFIC: COMPANY SNAPSHOT (2019)
    • 11.1.9 WUXI APPTEC
    • FIGURE 35 WUXI APPTEC: COMPANY SNAPSHOT (2019)
    • 11.1.10 STERIS PLC
    • FIGURE 36 STERIS PLC: COMPANY SNAPSHOT (2019)
  • 11.2 OTHER PLAYERS
    • 11.2.1 ELLAB A/S
    • 11.2.2 FUJIFILM WAKO PURE CHEMICAL CORPORATION
    • 11.2.3 INVIVOGEN
    • 11.2.4 NELSON LABORATORIES, LLC
    • 11.2.5 MICROCOAT BIOTECHNOLOGIE GMBH
    • 11.2.6 HYCULT BIOTECH
    • 11.2.7 ALMAC GROUP
    • 11.2.8 PACIFIC BIOLABS
    • 11.2.9 ACCUGEN LABORATORIES, INC.
    • 11.2.10 TOXIKON
    • 11.2.11 MINERVA ANALYTIX GMBH
    • 11.2.12 INDOOR BIOTECHNOLOGIES, INC.
    • 11.2.13 CREATIVE BIOARRAY
    • 11.2.14 LUCIDEON LIMITED
    • 11.2.15 NORTH AMERICAN SCIENCE ASSOCIATES, INC.

*Business Overview, Products Offered, Recent Developments, MnM View might not be captured in case of unlisted companies.

12 APPENDIX

  • 12.1 INSIGHTS FROM INDUSTRY EXPERTS
  • 12.2 DISCUSSION GUIDE
  • 12.3 KNOWLEDGE STORE: MARKETSANDMARKETS' SUBSCRIPTION PORTAL
  • 12.4 AVAILABLE CUSTOMIZATIONS
  • 12.5 RELATED REPORTS
  • 12.6 AUTHOR DETAILS